Company intelligence / Profile preview

Applied Biology, Inc.

Ownership: Private
Development stage: Other

Overview

Applied Biology, Inc. specializes in the development of breakthrough drugs and medical devices for the treatment of skin and hair disorders. The company has a robust pipeline with multiple candidates in advanced clinical stages, including treatments for various forms of alopecia, psoriasis, canities, drug-related side effects/adverse reactions, and women’s health conditions. Their expertise spans regulatory affairs across major global agencies. In June 2022, Jupiter Wellness acquired all assets of Applied Biology to expand its dermatology pipeline.

Therapeutic areas: OtherWomen's HealthOncologyDermatology
Modalities: Small molecule drugsChemical drugsMedical devices
Industry: Biotech

Partnerships

Exclusive license agreement with Jupiter Wellness for Photocil™ psoriasis treatment prior to full acquisitionCRO services provided to other healthcare companies globally.

Beyond the preview

Go deeper on Applied Biology, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applied Biology, Inc..